Target intelligence / Profile preview

Renal ion channels and transporters

Molecular classification
Ion channel, Transporter, Solute carrier (SLC), ATP-binding cassette (ABC) transporter
01

Overview

Renal ion channels and transporters are a diverse group of membrane proteins, primarily belonging to the Solute Carrier (SLC) and ATP-Binding Cassette (ABC) superfamilies, located along the various segments of the nephron [4, 6]. They are essential for maintaining systemic homeostasis by regulating the precise reabsorption and secretion of water, electrolytes (such as sodium, potassium, and chloride), nutrients (like glucose and amino acids), and metabolic waste products [3, 7]. These proteins are major therapeutic targets; for instance, diuretics modulate ion transporters like NKCC2 and NCC to treat hypertension and edema, while SGLT2 inhibitors target glucose transporters for the management of type 2 diabetes and heart failure [12, 4]. Dysregulation or genetic mutations in these channels and transporters are linked to numerous conditions, including chronic kidney disease, renal tubular disorders (e.g., Bartter and Gitelman syndromes), and systemic electrolyte disturbances [3, 8]. Furthermore, they play a critical role in the pharmacokinetics of many drugs, serving as both mediators of renal clearance and sites for potential drug-drug interactions [9, 11].

Other names
Kidney transportersRenal solute carriersRenal ion channelsNephron transport proteinsRenal membrane transporters
02

Mechanism of action

Inhibition or modulation of specific transport proteins (e.g., NKCC2, NCC, ENaC, SGLT2, URAT1) to regulate the reabsorption or secretion of ions, water, and solutes in the nephron.

03

Biological functions

Electrolyte homeostasisFluid balanceAcid-base regulationNutrient reabsorptionWaste excretionDrug elimination
04

Disease associations

HypertensionEdemaChronic kidney diseaseAcute kidney injuryDiabetes mellitusGoutRenal tubular acidosisBartter syndromeGitelman syndrome
05

Safety considerations

Electrolyte disturbances (e.g., hypokalemia, hyperkalemia, hyponatremia)DehydrationHypotensionAcute kidney injuryMetabolic acidosis or alkalosisDrug-drug interactions due to transporter competition
06

Interacting drugs

Furosemide

8 more in the full profile.

07

Biomarkers

Serum electrolytes (Sodium, Potassium, Chloride, Magnesium, Calcium)Glomerular filtration rate (GFR)Blood urea nitrogen (BUN)Urinary glucoseBlood pressureUrinary electrolyte excretion

Beyond the preview

Go deeper on Renal ion channels and transporters.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Renal ion channels and transporters.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call